136 related articles for article (PubMed ID: 26463450)
1. The role of host microfilaments and microtubules during opsonin-independent interactions of Cryptococcus neoformans with mammalian lung cells.
Choo KK; Chong PP; Ho AS; Yong PV
Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2421-7. PubMed ID: 26463450
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.
Giles SS; Zaas AK; Reidy MF; Perfect JR; Wright JR
PLoS One; 2007 Dec; 2(12):e1370. PubMed ID: 18159253
[TBL] [Abstract][Full Text] [Related]
3. The in vitro interaction of Cryptococcus neoformans with human lung epithelial cells.
Merkel GJ; Scofield BA
FEMS Immunol Med Microbiol; 1997 Nov; 19(3):203-13. PubMed ID: 9453390
[TBL] [Abstract][Full Text] [Related]
4. Reduced phagocytosis and killing of Cryptococcus neoformans biofilm-derived cells by J774.16 macrophages is associated with fungal capsular production and surface modification.
Lee HH; Del Pozzo J; Salamanca SA; Hernandez H; Martinez LR
Fungal Genet Biol; 2019 Nov; 132():103258. PubMed ID: 31356873
[TBL] [Abstract][Full Text] [Related]
5. The heat shock protein (Hsp) 70 of Cryptococcus neoformans is associated with the fungal cell surface and influences the interaction between yeast and host cells.
Silveira CP; Piffer AC; Kmetzsch L; Fonseca FL; Soares DA; Staats CC; Rodrigues ML; Schrank A; Vainstein MH
Fungal Genet Biol; 2013 Nov; 60():53-63. PubMed ID: 23954835
[TBL] [Abstract][Full Text] [Related]
6. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage.
Barbosa FM; Fonseca FL; Holandino C; Alviano CS; Nimrichter L; Rodrigues ML
Microbes Infect; 2006 Feb; 8(2):493-502. PubMed ID: 16293436
[TBL] [Abstract][Full Text] [Related]
7. A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection.
Srikanta D; Yang M; Williams M; Doering TL
PLoS One; 2011; 6(7):e22773. PubMed ID: 21829509
[TBL] [Abstract][Full Text] [Related]
8. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
9. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages.
Alvarez M; Casadevall A
Curr Biol; 2006 Nov; 16(21):2161-5. PubMed ID: 17084702
[TBL] [Abstract][Full Text] [Related]
10. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.
Ibrahim AS; Filler SG; Alcouloumre MS; Kozel TR; Edwards JE; Ghannoum MA
Infect Immun; 1995 Nov; 63(11):4368-74. PubMed ID: 7591072
[TBL] [Abstract][Full Text] [Related]
11. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
Cross CE; Bancroft GJ
Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
[TBL] [Abstract][Full Text] [Related]
12. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
Levitz SM; Tabuni A
J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
[TBL] [Abstract][Full Text] [Related]
13. The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation.
Johnston SA; May RC
PLoS Pathog; 2010 Aug; 6(8):e1001041. PubMed ID: 20714349
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides.
Xiao G; Miyazato A; Inden K; Nakamura K; Shiratori K; Nakagawa K; Miyazawa T; Suzuki K; Kaku M; Kawakami K
Microbiol Immunol; 2008 Mar; 52(3):171-9. PubMed ID: 18402599
[TBL] [Abstract][Full Text] [Related]
15. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.
García-Rodas R; Zaragoza O
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):147-61. PubMed ID: 22029633
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
17. Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells.
Teixeira PA; Penha LL; Mendonça-Previato L; Previato JO
Front Cell Infect Microbiol; 2014; 4():106. PubMed ID: 25191644
[TBL] [Abstract][Full Text] [Related]
18. Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome.
Guo C; Chen M; Fa Z; Lu A; Fang W; Sun B; Chen C; Liao W; Meng G
Microbes Infect; 2014 Oct; 16(10):845-54. PubMed ID: 25193031
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader.
Walenkamp AM; Scharringa J; Schramel FM; Coenjaerts FE; Hoepelman IM
J Microbiol Methods; 2000 Mar; 40(1):39-45. PubMed ID: 10739341
[TBL] [Abstract][Full Text] [Related]
20. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages.
Chrisman CJ; Albuquerque P; Guimaraes AJ; Nieves E; Casadevall A
PLoS Pathog; 2011 May; 7(5):e1002047. PubMed ID: 21637814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
